PHVS
Pharvaris N.v.
Late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists
CUSIP: N69605108HealthcareCH1 holder
Recent Activity
2024Q1
1 sell
-3.6K shares(-0.1%)
-3.6K shares(-0.1%)
Loading more activity...
Pharvaris N.v.
Late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists